PAUL-EHRLICH-INSTITUT

The Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency EMA has started the second rolling review process for...

The Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, has approved a Phase II clinical trial of a vaccine against COVID-19...

Vaccines can prevent more than two million deaths every year. The International Coalition of Medicines Regulatory Agencies, ICMRA has published...

The Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines has changed over its processes in the area of product testing to the...

Again this year, drug regulatory authorities around the world have partnered in the joint campaign called "MedSafetyWeek". In the light of the...

The Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMA) started the rolling review process - the...

Our reference: Trade name: International non-proprietary Name / Common name: Batch numbers appearing on package and other identification numbers...

On 22 November 2021, the Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMA) started its review of the...

A research team at the Paul-Ehrlich-Institut has compared the antibodies formed after vaccination with the COVID-19 Comirnaty vaccine from...

The Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedical Medicines, has approved phase II/III clinical testing of a vaccine...